Literature DB >> 24419742

Influence of Helicobacter pylori infection on metabolic parameters and body composition of dyslipidemic patients.

Elena Moretti1, Stefano Gonnelli, Mariastella Campagna, Ranuccio Nuti, Giulia Collodel, Natale Figura.   

Abstract

Helicobacter pylori infection may contribute to the development of extra-gastroduodenal diseases. The aim of this study was to explore whether this infection could influence metabolic parameters and body composition of dyslipidemic patients. In an 8-month period, 155 patients attended our clinic; 110 patients (48 men and 62 women, age 35-55 years) fulfilled inclusion criteria. Metabolic parameters were determined by routine tests and body composition by anthropometry and bioelectrical impedance analysis. The H. pylori and CagA infectious status were examined serologically. Sixty-one patients (55.4%) had serum antibodies to H. pylori and 30 infected patients (49.1%) had anti-CagA antibodies. The mean percentage of fat mass and level of high-density protein cholesterol in seropositive patients were significantly lower than those measured in seronegative ones (P = 0.008 and P < 0.001, respectively). The mean glucose concentration in patients with anti-H. pylori serum IgG was significantly higher than in uninfected patients (P = 0.021). No significant difference was observed regarding the other parameters. The CagA status did not influence any of the considered parameters. Our results are in agreement with those of other studies; however, the level of concordance of results reported in the various publications on this topic is very low, presumably from differences concerning the age, alimentary habits and possible presence of different pathologies in the groups studied. The most plausible hypothesis for the observed alterations may exist in the low-grade systemic inflammatory status of infected individuals, which may influence the fat turnover and support the insulin resistance with consequent alteration of glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24419742     DOI: 10.1007/s11739-013-1043-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  48 in total

1.  Association of inflammation and cytotoxin-associated gene a positive strains of helicobacter pylori in cardiac syndrome x.

Authors:  Yousef Rasmi; Sina Raeisi; Mir H Seyyed Mohammadzad
Journal:  Helicobacter       Date:  2012-04       Impact factor: 5.753

Review 2.  Extragastric manifestations of Helicobacter pylori infection.

Authors:  Natale Figura; Francesco Franceschi; Annalisa Santucci; Giulia Bernardini; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  Helicobacter       Date:  2010-09       Impact factor: 5.753

3.  Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile.

Authors:  A Hoffmeister; D Rothenbacher; G Bode; K Persson; W März; M A Nauck; H Brenner; V Hombach; W Koenig
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-03       Impact factor: 8.311

4.  Helicobacter pylori infection and chronic urticaria.

Authors:  B Tebbe; C C Geilen; J D Schulzke; C Bojarski; M Radenhausen; C E Orfanos
Journal:  J Am Acad Dermatol       Date:  1996-04       Impact factor: 11.527

5.  Fibrinogen: a link between chronic infection and coronary heart disease.

Authors:  P Patel; D Carrington; D P Strachan; E Leatham; P Goggin; T C Northfield; M A Mendall
Journal:  Lancet       Date:  1994-06-25       Impact factor: 79.321

Review 6.  Inflammation, stress, and diabetes.

Authors:  Kathryn E Wellen; Gökhan S Hotamisligil
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

7.  Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death.

Authors:  Jianhui Zhu; Arshed A Quyyumi; Joseph B Muhlestein; F Javier Nieto; Benjamin D Horne; Alexandra Zalles-Ganley; Jeffrey L Anderson; Stephen E Epstein
Journal:  Am J Cardiol       Date:  2002-01-15       Impact factor: 2.778

8.  The prevalence of Helicobacter pylori in obese subjects.

Authors:  Erol Arslan; Halil Atilgan; Irfan Yavaşoğlu
Journal:  Eur J Intern Med       Date:  2009-08-27       Impact factor: 4.487

9.  Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class.

Authors:  L J Murray; K B Bamford; D P O'Reilly; E E McCrum; A E Evans
Journal:  Br Heart J       Date:  1995-11

10.  Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis.

Authors:  En-Zhi Jia; Fu-Jun Zhao; Bo Hao; Tie-Bing Zhu; Lian-Sheng Wang; Bo Chen; Ke-Jiang Cao; Jun Huang; Wen-Zhu Ma; Zhi-Jian Yang; Guoxin Zhang
Journal:  Lipids Health Dis       Date:  2009-12-23       Impact factor: 3.876

View more
  3 in total

1.  Role of Helicobacter pylori and interleukin 6 -174 gene polymorphism in dyslipidemia: a case-control study.

Authors:  Vesa-Matti Pohjanen; Olli-Pekka Koivurova; Seppo E Niemelä; Riitta A Karttunen; Tuomo J Karttunen
Journal:  BMJ Open       Date:  2016-01-18       Impact factor: 2.692

2.  Association of Helicobacter pylori infection with metabolic parameters and dietary habits among medical undergraduate students in southeastern of Iran.

Authors:  Omid Eslami; Mansour Shahraki; Touran Shahraki; Hossein Ansari
Journal:  J Res Med Sci       Date:  2017-01-27       Impact factor: 1.852

Review 3.  Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders?

Authors:  Gracia M Martin-Nuñez; Isabel Cornejo-Pareja; Mercedes Clemente-Postigo; Francisco J Tinahones
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.